Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1030 (LINC01030) is a non-coding RNA gene located in an intergenic region of the human genome, meaning it does not overlap with any protein-coding genes[1][2]. Like other long intergenic non-coding RNAs (lincRNAs), LINC01030 is presumed to regulate gene expression through various mechanisms, including interaction with chromatin-modifying complexes, RNA-binding proteins, or through the modulation of chromatin architecture and nuclear structure[2][3][4]. LincRNAs are known for their tissue-specific expression and are increasingly recognized for their potential roles in developmental regulation and disease, especially cancer, but only a small subset of lincRNAs have characterized functions, and LINC01030-specific biological roles and disease associations have not yet been elaborated in scientific literature[1][2]. No drugs or targeted therapies are currently associated with this lincRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1030 (LINC01030).